Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
J. Clin. Invest. 113:11 doi:10.1172/JCI18704
[Go to this article.]
Options: View larger image (or click on image)
Medium
Figure 4

RAGE–/– and Tie2RAGE mice develop a normal immune response in EAE. Age- and sex-matched mice were sensitized against oligodendrocyte glycoprotein (MOG35–55) and were monitored for the onset of clinical signs on a daily basis (see Methods). (A) EAE response in WT and RAGE–/– mice. WT indicates C57BL/6 ∞ 129/Sv mice. The mean clinical score represents a summary of two independent experiments each for WT and for RAGE–/–. WT, filled squares; RAGE–/–, open circles. (B) EAE response in WT and Tie2RAGE mice. WT mice used were transgene-negative littermates. The mean clinical score represents a summary of two independent experiments each for WT and for Tie2RAGE. WT, filled squares; Tie2RAGE, open triangles. The standard error of the mean is given (± SEM), and P < 0.05 was considered to be statistically significant.